Concepedia

George Birchfield

GB

Statistics

Publications

4

Citations

127

H-Index

4

Active since

1989

Affiliations

University of Utah(Current)

George Birchfield is an author at University of Utah specializing in oncology, medicine, and tumor immunology.

Publications per year

1989–2011

4

Publications

4

Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer

Leonard B. Saltz, Suprith Badarinath, Shaker R. Dakhil et al. · Clinical Colorectal Cancer · 2011 · 69 citations

, , +11

Hypocholesterolemia in patients treated with recombinant interleukin-2: appearance of remnant-like lipoproteins.

Daniel E. Wilson, George Birchfield, J. Hejazi et al. · Journal of Clinical Oncology · 1989 · 28 citations

, , +17

Hypoprothrombinemia Associated with Interleukin-2 Therapy

George Birchfield, George M. Rodgers, Kenneth W. Girodias et al. · Journal of Immunotherapy · 1992 · 16 citations

, , +17

Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanoma.

George Birchfield, John H. Ward, Bruce G. Redman et al. · PubMed · 1990 · 14 citations · Full text

, , +10

1–4 of 4